Studiedocumentatie
Open studies |
Trial | MAGNAZ trial | ||||
Middelen | Rituximab (via SOC) | ||||
Lijn | Leeftijd | Fase | Location | Status | |
---|---|---|---|---|---|
N.v.t. | ≥ 18 jaar | Fase 2 | Amsterdam UMC | Open |
Open studies |
Trial | MAGNAZ trial | ||||
Middelen | Rituximab (via SOC) | ||||
Lijn | Leeftijd | Fase | Location | Status | |
---|---|---|---|---|---|
N.v.t. | ≥ 18 jaar | Fase 2 | Amsterdam UMC | Open |